C1 inhibitor - Revision history

Josgood: /* Administration */

2020-08-16T14:30:49Z

Administration

← Older revision		Revision as of 14:30, 16 August 2020
Line 1:		Line 1:
	==Administration==		==Administration==
	*Type:		*Type: human C1 inhibitor (plasma product)
	*Dosage Forms:		*Dosage Forms: 20 iU/kg
	*Routes of Administration:		*Routes of Administration: IV/SQ
	*Common Trade Names: ~~C1INH~~		*Common Trade Names: Cinryze, Berinert

	==Adult Dosing==		==Adult Dosing==

Rossdonaldson1: /* AngioedemaCraig TJ, Levy RJ, Wasserman RL, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol. 2009; 124(4):801. */

2019-08-17T16:03:33Z

AngioedemaCraig TJ, Levy RJ, Wasserman RL, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol. 2009; 124(4):801.

← Older revision		Revision as of 16:03, 17 August 2019
Line 6:		Line 6:

	==Adult Dosing==		==Adult Dosing==
	===Angioedema<ref>Craig TJ, Levy RJ, Wasserman RL, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol. 2009; 124(4):801.</ref>===		===[[Angioedema]]<ref>Craig TJ, Levy RJ, Wasserman RL, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol. 2009; 124(4):801.</ref>===
	*1000 units if ≤50kg		*1000 units if ≤50kg
	*1500 units if >50-75kg		*1500 units if >50-75kg

Rossdonaldson1: Created page with "==Administration== Type: Dosage Forms: Routes of Administration: Common Trade Names: C1INH ==Adult Dosing== ===AngioedemaCraig TJ, Levy RJ, Wasserman RL, et al. Eff..."

2019-08-17T16:02:55Z

Created page with "==Administration== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: C1INH ==Adult Dosing== ===Angioedema<ref>Craig TJ, Levy RJ, Wasserman RL, et al. Eff..."

New page

==Administration==
*Type:
*Dosage Forms:
*Routes of Administration:
*Common Trade Names: C1INH

==Adult Dosing==
===Angioedema<ref>Craig TJ, Levy RJ, Wasserman RL, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol. 2009; 124(4):801.</ref>===
*1000 units if ≤50kg
*1500 units if >50-75kg
*2000 units if >75-100kg
*2500 units if >100kg

==Pediatric Dosing==

==Special Populations==
===[[Drug pregnancy categories|Pregnancy Rating]]===
*

===Lactation risk===
*

===Renal Dosing===
*Adult:
*Pediatric:

===Hepatic Dosing===
*Adult:
*Pediatric:

==Contraindications==
*Allergy to class/drug

==Adverse Reactions==
===Serious===

===Common===

==Pharmacology==
*Half-life:
*Metabolism:
*Excretion:

==Mechanism of Action==

==Comments==

==See Also==

==References==
<references/>

[[Category:Pharmacology]]

C1 inhibitor - Revision history

Josgood: /* Administration */

Rossdonaldson1: /* AngioedemaCraig TJ, Levy RJ, Wasserman RL, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol. 2009; 124(4):801. */

Rossdonaldson1: Created page with "==Administration== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: C1INH ==Adult Dosing== ===AngioedemaCraig TJ, Levy RJ, Wasserman RL, et al. Eff..."

Rossdonaldson1: Created page with "==Administration== Type: Dosage Forms: Routes of Administration: Common Trade Names: C1INH ==Adult Dosing== ===AngioedemaCraig TJ, Levy RJ, Wasserman RL, et al. Eff..."